Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.Business Wire • 11/30/22
Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.Business Wire • 11/08/22
Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle SolutionsBusiness Wire • 10/25/22
Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public OfferingBusiness Wire • 10/14/22
Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, SofthreadBusiness Wire • 10/12/22
Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third QuarterBusiness Wire • 07/14/22
Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third QuarterBusiness Wire • 07/11/22
Novo Integrated Sciences' Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and BeyondBusiness Wire • 06/23/22
Novo Integrated Sciences' Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTPBusiness Wire • 04/26/22
Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial ResultsBusiness Wire • 04/13/22
Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLCBusiness Wire • 04/07/22
Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North AmericaBusiness Wire • 03/29/22